Press Release – RepliCel Receives Issue Notification from USPTO

Snippet from the press release:

RepliCel Life Sciences Inc. is pleased to announce that it has received issue notification from the United States Patent and Trademark Office with respect to RepliCel’s technology for preparing populations of dermal sheath cup cells for its hair regeneration procedure. These cells are used to treat patients suffering from androgenetic alopecia, also known as pattern hair loss. With the issuance of this patent, RepliCel will now have patents issued in the United States, Australia and the European Union. Additional patent applications, further protecting and expanding on our technology, are pending in the European Union, Canada, Japan, the United States, as well as other countries.

Read the rest — RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for Its Hair Regeneration Technology

I don’t know what it means for the viability of hair regeneration, but they are proud to announce they’re getting patents on their technology.